10/29/2026
A recent HHS policy update addresses enforcement discretion for six peptides (BPC-157, Epitalon, KPV, MOTS-c, Semax, and TB-500), while formal rulemaking continues.
This does not mean FDA approval or blanket authorization for compounding. Eagle Analytical is monitoring these developments and evolving testing requirements.
As these regulatory developments unfold, access to laboratories with specialized peptide testing capabilities is increasingly important.
Eagle Analytical, an FDA- and DEA-registered, A2LA ISO/IEC 17025-accredited laboratory (Cert. 3980.01 & 3980.02), is among a limited number of U.S. laboratories with specialized peptide testing capabilities to support product development and quality assessment. Our services include, but not limited to:
- Peptide identification and purity testing
- Peptide mapping and impurity analysis
- Microbiological testing
- Stability studies
- Method development and validation
Contact Eagle Analytical to discuss your peptide testing needs.